Join to View Full Profile
4881 NE Goodview CircleLee's Summit, MO 64064
Phone+1 913-588-1227
Dr. Rader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ryan Rader is a Clinical Assistant Professor of Medical Oncology at the University of Kansas with a primary focus on breast cancer. He completed his Hematology/Oncology fellowship at Duke University and internal medicine residency at Cleveland Clinic. He received his medical degree from University of Missouri-Columbia School of Medicine.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
- Cleveland Clinic FoundationResidency, Internal Medicine, 2017 - 2020
- University of Missouri-Columbia School of MedicineClass of 2017
Certifications & Licensure
- MO State Medical License 2023 - 2026
- KS State Medical License 2023 - 2025
- NC State Medical License 2020 - 2024
- OH State Medical License 2020 - 2023
- AL State Medical License 2021 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer.Cindy Im, Hasibul Hasan, Emily Stene, Sarah Monick, Ryan K Rader
Nature Communications. 2025-03-31 - Cytomegalovirus Colitis Masquerading as a Recurrent Colonic Polyp in a Patient With Neurofibromatosis Type 1.Colin P Slaymaker, Bhargavram Channagiri Srinivas, Pranay Reddy, D Matthew Shoemaker, Andrea E Stand
ACG Case Reports Journal. 2025-01-01 - 3 citationsSafety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation D...Amanda Nizam, Ryan K Rader, Alice Tzeng, Wei Wei, Iris Yeong-Fung Sheng
Clinical Genitourinary Cancer. 2024-04-01
Press Mentions
- Patient Selection Takes Priority as Standard of Cares Shift in HR+ and HER2+ Breast CanceJuly 14th, 2024
Professional Memberships
- Missouri State Medical AssociationStudent Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: